日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Discordance in amyloid positivity between visual reads and Centiloids: Impact of white matter uptake

视觉判读与Centiloid检测结果中淀粉样蛋白阳性率的差异:白质摄取的影响

Charil, Arnaud; Nelson, Todd M; Reilhac, Anthonin; Devanarayan, Viswanath; Dhadda, Shobha; Irizarry, Michael C; Kramer, Lynn D; Reyderman, Larisa

Pharmacokinetic/pharmacodynamic analyses of plasma pathophysiology biomarkers in subjects with early Alzheimer's disease following lecanemab treatment

对接受lecanemab治疗的早期阿尔茨海默病患者进行血浆病理生理学生物标志物的药代动力学/药效学分析

Bhagunde, Pratik; Penner, Natasha; Willis, Brian A; Bell, Robert; Sachdev, Pallavi; Charil, Arnaud; Irizarry, Michael C; Hersch, Steven; Reyderman, Larisa

Brain Amyloid Plaque Levels Affect Clinical Progression in Alzheimer Disease: Assessment of Amyloid PET and Change in CDR-SB Utilizing Semi-Mechanistic Model

脑淀粉样斑块水平影响阿尔茨海默病临床进展:利用半机制模型评估淀粉样蛋白PET和CDR-SB变化

Bhagunde, Pratik; Penner, Natasha; Willis, Brian A; Bell, Robert; Charil, Arnaud; Irizarry, Michael C; Hersch, Steven; Reyderman, Larisa

Etalanetug (E2814) in dominantly inherited Alzheimer's disease: an open-label phase 1b/2 study to assess safety and target engagement in participants with mild to moderate cognitive impairment

Etalanetug (E2814) 在显性遗传性阿尔茨海默病中的应用:一项开放标签的 1b/2 期研究,旨在评估其在轻度至中度认知障碍患者中的安全性和靶点结合情况。

Andreozzi, Erica; Yagi, Takuya; Wildsmith, Kristin; Rawal, Sumit; Horie, Kanta; Boyd, Peter; Takahashi, Eri; Barthélemy, Nicolas R; Aluri, Jagadeesh; Charil, Arnaud; Reilhac, Anthonin; Gordon, Brian A; Flores, Shaney; Verbel, David; Sauter, Nicholas; Benzinger, Tammie L S; McDade, Eric; Mummery, Catherine; Zhou, Jin; Bateman, Randall J; Reyderman, Larisa

Neuro-Dynamic Quantitative Systems Pharmacology (QSP) model describing Alzheimer's disease pathophysiology and treatment effects

描述阿尔茨海默病病理生理学和治疗效果的神经动力学定量系统药理学(QSP)模型

Cao, Youfang; Willis, Brian A; Horie, Kanta; Wildsmith, Kristin R; Koyama, Akihiko; Sachdev, Pallavi; Penner, Natasha; Charil, Arnaud; Irizarry, Michael; Reyderman, Larisa

GDF15 protein as a complementary pathology biomarker of Alzheimer's Disease

GDF15蛋白作为阿尔茨海默病的一种辅助病理学生物标志物

Zeng, Xuemei; Deek, Rebecca A; Nafash, Michel N; Gu, Jeremy M; Choity, Lamia; Lafferty, Tara K; Farinas, Marissa F; Bedison, Margaret A; Mercurio, Rocco B; Matan, Cristy; Gogola, Alexandra; Kofler, Julia K; Tudorascu, Dana L; Shaaban, C Elizabeth; Lingler, Jennifer H; Pascoal, Tharick A; Klunk, William E; Villemagne, Victor L; Ikonomovic, Milos D; Berman, Sarah B; Sweet, Robert; Snitz, Beth E; Cohen, Ann D; Kamboh, M Ilyas; Lopez, Oscar L; Karikari, Thomas K; Cui, Mei; Jin, Zishuo; Wang, Yingzhe; Dong, Qiang; Kumari, Namrata; Sodders, Maggie; Marathi, Archana; Olsen, Abby; Potvin‐Trottier, Laurent; Guay‐Lord, Robin; Breuillaud, Lionel; Zehntner, Simone P; Brison, Elodie; Bedell, Barry J; Eslick, Shaun; Austin, Grace; Ferguson, Jessica; Oldmeadow, Christopher; Garg, Manohar; Martins, Ralph N; Jacobs, Tovia; Cejudo, Jaime Ramos; He, Mark; Muller, Matthew; Figueredo, Luisa F; Berger, Jeffrey S; Osorio, Ricardo S; Reyderman, Larisa; Penner, Natasha; Bhagunde, Pratik; Li, David; Dhadda, Shobha; Hersch, Steven; Irizarry, Michael C; Kramer, Lynn D; Koerich, Suelyn; Ramirez, Santiago; Astudillo, Natalia; Colpo, Gabriela Delevati; Soto, Claudio; Salvadori, Sofia Gallo; Baldasso, Gabriela Mantovani; Limberger, Christian; Zimmer, Eduardo R; Das, Glori; Raghunathan, Raksha; Wang, Lin; Wan, Zhihao; Zhao, Hong; Wong, Stephen TC; Kang, Heekyoung; Yoo, Heejin; Shin, Daeun; Seo, Sang Won; Manly, Jennifer J; Brickman, Adam; Kim, Soobin; Culbertson, Michael; Grodsky, Eric; Muller, Chandra; Warren, John Robert; Kanyinda, Jonathan Nyandu; Marola, Olivia J; Howell, Gareth R; Paes, Rodrigo Sebben; Baldasso, Gabriela Mantovani; Limberger, Christian; Zimmer, Eduardo R

Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease

血浆 pTau217 比值可预测淀粉样蛋白阳性早期阿尔茨海默病中脑内 tau 蛋白的持续区域性积累

Devanarayan, Viswanath; Charil, Arnaud; Horie, Kanta; Doherty, Thomas; Llano, Daniel A; Andreozzi, Erica; Sachdev, Pallavi; Ye, Yuanqing; Murali, Leema Krishna; Zhou, Jin; Reyderman, Larisa; Hampel, Harald; Kramer, Lynn D; Dhadda, Shobha; Irizarry, Michael C

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease

了解靶向β-淀粉样蛋白疗法对阿尔茨海默病生物标志物和临床终点的影响

Petersen, Ronald C; Graf, Ana; Atkins, Alexandra S; Brys, Miroslaw; Murphy, Jennifer; Miller, David S; Reyderman, Larisa; Siemers, Eric; Smith, Janice; Carrillo, Maria C; Weber, Christopher J

Tau biology, biomarkers, and therapeutics

Tau蛋白生物学、生物标志物和治疗方法

Frost, Bess; Kolb, Hartmuth; Algeciras-Schimnich, Alicia; Betthauser, Tobey J; DeVos, Sarah; Edelmayer, Rebecca M; Elwood, Fiona; Fleisher, Adam S; Henley, David; Horie, Kanta; Hyman, Bradley; Kreisl, William Charles; Kulic, Luka; Leuzy, Antoine; Palma, Jose-Alberto; Parmentier-Batteur, Sophie; Patru, Maria-Magdalena; Rabinovici, Gil D; Reyderman, Larisa; Sperling, Reisa A; Van Der Geyten, Serge; Wildsmith, Kristin R; Mahinrad, Simin; Carrillo, Maria C; Weber, Christopher J

An Anti-tau Therapeutic Antibody Etalanetug (E2814): A Phase 1, First-in-human (FIH) Study of Single and Multiple Ascending Doses in Healthy Subjects

抗tau治疗性抗体Etalanetug(E2814):一项针对健康受试者的单次和多次递增剂量I期首次人体(FIH)研究

Rawal, Sumit; Wildsmith, Kristin R; Aluri, Jagadeesh; Yagi, Takuya; Chang, Min-Kun; Niu, Hongmei; Zhou, Jin; Horie, Kanta; Takahashi, Eri; Boyd, Peter; Reyderman, Larisa